Quadron Announces Listing on the Canadian Securities Exchange
Vancouver, BC – Quadron Capital Corp. (CSE:QCC) (the “Company” or “Quadron”) is pleased to announce that the Company’s common shares will commence trading on the Canadian Securities Exchange (the “CSE”) under the trading symbol “QCC” at the opening of the market tomorrow, February 24, 2017.
About Quadron Capital
Quadron operates through its two subsidiaries: Soma Labs Scientific Inc. (“Soma”) and Greenmantle Products Limited (“Greenmantle”), providing ancillary equipment, products and services, designed and structured to address the complex needs and requirements of cannabis industry participants in Canada and the US. Soma provides research, services and production equipment to the biotech and bioceutical industries, including cannabis extraction and processing equipment that is being leased and/or sold to various industry participants. Greenmantle’s business involves the sale of ancillary cannabis products, such as customized dispensing devices (i.e. vaporizer pens) and consumption type products such as branded encapsulation products to authorized cannabis industry participants.
For more information, visit: www.quadroncapital.ca
For further information, contact Rosy Mondin at (604) 346-8118.
On behalf of the Board of Directors of
QUADRON CAPITAL CORPORATION
President, Director & CEO
Investor Relations Contact:
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as “forward-looking statements”. Forward-looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company’s future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.